drugset / Trial / NCT02308007

Multi-Center Study of New Medications to Treat Vaginal Infections

NCT02308007

Phase 3 Completed 475 enrolled Curatek Pharmaceuticals, LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of terconazole/metronidazole gel in the treatment of vaginal infections

Timeline

Start
2015-06
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule Other
Comparator Terconazole Small molecule Other

Indications